SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

73,123.83 -125.56
( -0.17%)

Global Indices

Nasdaq

52,230.09 -658.89
(-1.25%)

Dow Jones

7,644.13 -40.30
(-0.52%)

Hang Seng

62,584.98 -322.86
(-0.51%)

Nikkei 225

10,670.63 -54.40
(-0.51%)

Forex

USD-INR

94.61 0.10
(0.11%)

EUR-INR

106.18 0.08
(0.07%)

GBP-INR

126.70 0.19
(0.15%)

JPY-INR

0.60 0.00
(0.70%)

YOU ARE HERE :
HOME
Markets
Equity
Profit and Loss

EQUITY - MARKET SCREENER

Titan Biotech Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

524717

INE150C01029

33.0779675

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

54.76

1682.95

EPS(TTM)

Face Value()

Div & Yield %

5.95

0.12

Particulars(INCOME)	Mar 2026 ( Cr)	Mar 2025 ( Cr)	Mar 2024 ( Cr)	Mar 2023 ( Cr)	Mar 2022 ( Cr)	Mar 2021 ( Cr)
Sales Turnover	206.19	156.45	164.07	144.00	123.55	122.46
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	206.19	156.45	164.07	144.00	123.55	122.46
Other Income	5.41	3.91	1.75	1.94	0.94	0.75
Stock Adjustments	2.97	2.85	5.29	0.93	0.17	2.23
Total Income	214.57	163.21	171.11	146.87	124.66	125.44
EXPENDITURE :
Raw Materials	103.99	79.34	85.33	74.61	61.64	57.58
Power & Fuel Cost	12.76	9.83	10.24	8.98	6.67	4.10
Employee Cost	32.36	26.38	23.71	18.21	14.24	11.08
Other Manufacturing Expenses	5.15	3.92	4.10	3.44	2.96	3.77
Selling & Administrative Expenses	15.04	13.44	10.75	9.21	6.42	5.66
Miscellaneous Expenses	1.26	0.96	0.95	0.96	0.52	1.05
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	170.56	133.88	135.07	115.42	92.46	83.23
Operating Profit	44.01	29.34	36.03	31.47	32.21	42.20
Interest	0.91	0.80	1.17	0.75	0.87	1.33
Gross Profit	43.10	28.54	34.86	30.72	31.34	40.87
Depreciation	4.93	4.17	3.33	2.60	2.37	2.10
Profit Before Tax	38.17	24.37	31.53	28.12	28.97	38.77
Tax	9.89	5.97	7.76	7.18	7.35	9.86
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	0.84	0.12	0.11	-0.09	-0.07	0.13
Reported Net Profit	27.45	18.27	23.66	21.02	21.68	28.77
Extraordinary Items	0.00	0.00	0.00	0.00	0.00	-0.24
Adjusted Net Profit	27.45	18.27	23.66	21.02	21.68	29.01
Adjustment below Net Profit	0.00	0.00	0.00	0.00	0.00	0.00
P & L Balance brought forward	127.80	111.18	89.00	69.22	48.77	20.83
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	1.65	1.65	1.49	1.24	1.24	0.83
P & L Balance carried down	153.59	127.80	111.18	89.00	69.22	48.77
Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	25.00	20.00	20.00	18.00	15.00	15.00
Dividend Per Share(Rs)	0.50	2.00	2.00	1.80	1.50	1.50
Earnings Per Share-Unit Curr	6.64	22.11	28.64	25.44	26.24	34.82
Earnings Per Share(Adj)-Unit Curr	5.31	3.54	4.58	4.07	4.20	5.57
Book Value-Unit Curr	41.35	175.63	155.43	128.38	104.36	79.65
Book Value(Adj)-Unit Curr	33.08	28.10	24.87	20.54	16.70	12.74

73,123.83 -125.56 ( -0.17%)

52,230.09 -658.89 (-1.25%)

7,644.13 -40.30 (-0.52%)

62,584.98 -322.86 (-0.51%)

10,670.63 -54.40 (-0.51%)

94.61 0.10 (0.11%)

106.18 0.08 (0.07%)

126.70 0.19 (0.15%)

0.60 0.00 (0.70%)